About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Georgia | 20,355 Studies Near You

Clinical TrialsGeorgia

Clinical Trials in Georgia

Discover 20,355 clinical trials near Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2241-2260 of 20,355 trials

CompletedStudy of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic MelanomaThis is a phase 1, multicenter, nonrandomized, open-label, dose escalation study. The study will be conducted in 2 stages, Dose Escalation and Dose Expansion.NCT01425008·San Francisco, California and 15 others RecruitingEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection FractionThis study is a small, early-stage clinical trial designed to test whether a new catheter-based procedure is safe and may help people with heart failure with reduced ejection…NCT07403058·Prague and 8 others

Find Trials by Condition in Georgia

Breast Cancerin Georgia Lung Cancerin Georgia Prostate Cancerin Georgia Colorectal Cancerin Georgia Melanomain Georgia Leukemiain Georgia Lymphomain Georgia Pancreatic Cancerin Georgia Ovarian Cancerin Georgia Brain Cancerin Georgia Diabetes

Data from ClinicalTrials.govTerms

CompletedRE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary SyndromeThe purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to…NCT00621855·Clearwater, Florida and 166 others

CompletedPharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's DiseaseTo study the profile of Neupro patch administrated at 2 mg, 4 mg, 6 mg and 8 mg/day weekly in patients with early-stage Parkinson's diseaseNCT02728947·Long Beach, California and 2 others

CompletedA Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del MutationThe purpose of this study is to evaluate the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who are homozygous for F508del…NCT05076149·Birmingham, Alabama and 169 others

CompletedPyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006355·Birmingham, Alabama and 7 others

Active not recruitingA Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsThe purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients…NCT06857955·Andalusia, Alabama and 71 others

CompletedA Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisThe objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission (per Adapted Mayo score) in participants with…NCT03653026·Mobile, Alabama and 378 others

CompletedA Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)This study will evaluate the efficacy, safety, and tolerability of adjunctive ALKS 5461 in adults who have treatment refractory MDD.NCT03188185·Tucson, Arizona and 34 others

TerminatedEndoPredict® Extended Endocrine Trial (EXET)The purpose of this study is to evaluate the impact of using EndoPredict® clinically to inform treatment decisions for extended endocrine therapy, and the subsequent impact on…NCT04016935·Burbank, California and 51 others

CompletedPilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill ChildrenHypothesis 1: Blood alcohol concentration will be \<25 mg/100ml (equivalent to a blood alcohol concentration of \<0.025%) after a 1 hour urinary catheter ethanol lock.NCT01865708·Atlanta, Georgia

CompletedUNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated CirrhosisTo demonstrate the effectiveness of DCV 3DAA fixed dose combination with or without Ribavirin in treatment naive cirrhotic subjects.NCT01973049·La Jolla, California and 48 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT06042855·Chandler, Arizona and 109 others

TerminatedAn Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)This study will investigate the efficacy, safety and tolerability of a new formulation of glatiramer acetate administered at 20 mg/0.5 ml daily versus placebo in patients with…NCT01578785·Cullman, Alabama and 168 others

CompletedSafety and Performance Study of the INGEVITY LeadThe objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads.NCT01688843·Gilbert, Arizona and 77 others

Enrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0There is a growing focus on short- and long-term kidney health in neonates, including those with acute kidney injury (AKI).NCT06823115·Birmingham, Alabama and 124 others

CompletedA Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)This is a Phase III, multicenter, randomized, double-masked, dose-comparison study of the efficacy and safety of ranibizumab injection administered intravitreally to patients with…NCT00891735·Phoenix, Arizona and 98 others

Active not recruitingLung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis randomized phase III trial compares nivolumab with ipilimumab and nivolumab alone in treating patients with stage IV squamous cell lung cancer that has come back after…NCT02785952·Birmingham, Alabama and 1206 others

CompletedAccolade® TMZF® Hip Stem Outcomes StudyThe purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.NCT00957658·Newport Beach, California and 10 others

CompletedInsulin Detemir Versus NPH Insulin In Hospitalized Patients With DiabetesHigh blood glucose levels in hospitalized patients with diabetes are associated with increased risk of medical complications.NCT00590226·Atlanta, Georgia and 1 other

PreviousPage 113 of 1018Next

in Georgia

Heart Diseasein Georgia